Picture of Alk-Abello A/S logo

ALK B — Alk-Abello A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: ALK-Abello Says Neffy Approved In Canada

April 15 (Reuters) - ALK-Abello A/S ALKb.CO:

NEFFY APPROVED AS FIRST NEEDLE-FREE ANAPHYLAXIS TREATMENT OF ADULTS AND CHILDREN IN CANADA

HEALTH CANADA APPROVES NEFFY 2 MG FOR EMERGENCY ANAPHYLAXIS TREATMENT IN ADULTS AND CHILDREN

APPROVAL DOES NOT AFFECT CO'S FINANCIAL GUIDANCE FOR 2026

Source text: ID:nGNE90Nj4V

Further company coverage: [ALKb.CO]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Alk-Abello A/S

See all news